Will Collegium Pharmaceutical, Inc. (COLL) stock recover?
What do analysts say about COLL?
Average price target from 6 analysts: $47 over ~12 months (Buy consensus), i.e. +118 % from the current price. Most reliable firm on COLL: Needham (71% hit rate, 21 scored calls). A target is a 12-month view, not for tomorrow.
What happened after its past drops?
Over 2015-2026, Collegium Pharmaceutical, Inc. saw 7 drops of 30%+. Twelve months later it was +45 % on median (positive 71% of the time). It regained its pre-crash high in 71% of cases, in about 9 months. (monthly history 2015-2026 — transparency data, not a guarantee)
COLL's biggest months
⚠️ Drop measured from the 12-month high; analyst targets on a ~12-month horizon; monthly history since 2013. Information, not investment advice. Past performance does not guarantee future results.
Frequently asked questions
Will Collegium Pharmaceutical, Inc. stock recover?
No one can guarantee it, and we won't. What we know: it's down 53 % from its high; analysts target $47 over 12 months (+118 % from the current price). Over 2015-2026, Collegium Pharmaceutical, Inc. saw 7 drops of 30%+. Twelve months later it was +45 % on median (positive 71% of the time). It regained its pre-crash high in 71% of cases, in about 9 months. Past performance does not guarantee future results.
Why has COLL dropped so much?
We don't assert the cause of a drop — a headline can be a consequence or a coincidence. What we measure is what comes next: the analysts' target and the stock's historical behavior after this kind of drop.
Should I buy COLL now that it's down?
A drop is not a buy signal by itself. Cross-check with the analysts' target, their real reliability on the stock (most solid: Needham, 71% hit rate), and the fundamentals. This is not personalized advice.